Search results
Collegium Pharmaceutical, Inc.'s (NASDAQ:COLL) CEO Looks Like They Deserve Their Pay Packet
Simply Wall St. via Yahoo Finance· 3 weeks agoKey Insights Collegium Pharmaceutical to hold its Annual General Meeting on 16th of May Salary of...
Collegium Pharmaceutical, Inc. (NASDAQ:COLL) Q4 2022 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 1 year agoCollegium Pharmaceutical, Inc. (NASDAQ:COLL) Q4 2022 Earnings Call Transcript February 23, 2023...
Collegium Pharmaceutical (COLL) Q1 Earnings Meet Estimates
Zacks via Yahoo Finance· 1 year agoCollegium Pharmaceutical (COLL) delivered earnings and revenue surprises of 0% and 4.07%,...
Collegium Pharmaceutical (COLL) Earnings Expected to Grow: Should You Buy?
Zacks via Yahoo Finance· 1 year agoCollegium Pharmaceutical (COLL) doesn't possess the right combination of the two key ingredients for...
Insider Sell: EVP and General Counsel Shirley Kuhlmann Sells 25,600 Shares of Collegium ...
GuruFocus.com via Yahoo Finance· 6 months agoShirley Kuhlmann, the Executive Vice President and General Counsel of Collegium Pharmaceutical Inc,...
Collegium (COLL) Shares Rise on Financial Outlook for 2024
Zacks via Yahoo Finance· 5 months agoShares of Collegium Pharmaceutical, Inc. COLL were up 8.4% on Jan 3 after it announced its full-year...
Collegium (COLL) to Report Q1 Earnings: Here's What to Expect
Zacks via Yahoo Finance· 1 month agoInvestors are expected to focus on top and bottom-line growth when Collegium Pharmaceutical COLL...
Strength Seen in Collegium Pharmaceutical (COLL): Can Its 8.4% Jump Turn into More Strength?
Zacks via Yahoo Finance· 5 months agoCollegium Pharmaceutical (COLL) was a big mover last session on higher-than-average trading volume....
Collegium Pharmaceutical (NASDAQ:COLL) shareholders have earned a 6.8% CAGR over the last five years
Simply Wall St. via Yahoo Finance· 2 years agoCollegium Pharmaceutical, Inc. (NASDAQ:COLL) shareholders might be concerned after seeing the share...
Collegium Pharmaceutical Inc CEO Joseph Ciaffoni Sells 68,768 Shares
GuruFocus.com via Yahoo Finance· 5 months agoJoseph Ciaffoni, the President and CEO of Collegium Pharmaceutical Inc (NASDAQ:COLL), sold 68,768...